Chronic Myelomonocytic Leukemia Completed Phase 1 / 2 Trials for Idarubicin (DB01177)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096122Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid LeukemiaTreatment